Model of intestinal chylomicron over-production and Ezetimibe treatment: Impact on the retention of cholesterol in arterial vessels-Reference-Cited by-同舟云学术

Model of intestinal chylomicron over-production and Ezetimibe treatment: Impact on the retention of cholesterol in arterial vessels

Published:2010-06 Issue:1 Volume:11 Page:17-24
ISSN:1567-5688
Container-title:Atherosclerosis Supplements
language:en
Short-container-title:Atherosclerosis Supplements

Author:

Mangat R.,Warnakula S.,Wang Y.,Russell J.C.,Uwiera R.,Vine D.F.,Proctor S.D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Reference48 articles.

1. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial;Colhoun;Lancet,2004

2. Blood lipid concentrations and risk of myocardial infarction;Mediene-Benchekor;Lancet,2001

3. Long-term effectiveness and safety of Pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up;LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease);Lancet,2002

4. Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome;Vine;Atherosclerosis,2007

5. Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis;Proctor;Curr Opin Lipidol,2002

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetic dyslipidemia: focus on pathogenesis and treatment;Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini;2022

2. Roles of Achieved Levels of Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein on Cardiovascular Outcome in Statin Therapy;Cardiovascular Therapeutics;2019-11-21

3. Gene expression profiles during subclinical Mycobacterium avium subspecies paratuberculosis infection in sheep can predict disease outcome;Scientific Reports;2019-06-03

4. Ezetimibe reduces cholesterol content and NF-kappaB activation in liver but not in intestinal tissue in guinea pigs;Journal of Inflammation;2017-02-02

5. Mechanisms of Comorbidities Associated With the Metabolic Syndrome: Insights from the JCR:LA-cp Corpulent Rat Strain;Frontiers in Nutrition;2016-10-10